Ubiquitylation of nuclear receptors: New linkages and therapeutic implications

Journal of Molecular Endocrinology

Volumn 54, Issue 3, 2015, Pages R151-R167

  Helzer, Kyle T ^a   Hooper, Christopher ^a   Miyamoto, Shigeki ^a   Alarid, Elaine T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

E3 ligase; NF kB; Proteasome; Steroid

Indexed keywords

CELL NUCLEUS RECEPTOR; HEAT SHOCK COGNATE PROTEIN 70; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; CELL RECEPTOR; UBIQUITIN PROTEIN LIGASE;

CARBOXY TERMINAL SEQUENCE; DRUG TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; UBIQUITINATION; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM; MOLECULARLY TARGETED THERAPY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR TARGETED THERAPY; PHOSPHORYLATION; PROTEIN STABILITY; PROTEOLYSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84947259866     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0308     Document Type: Review

References (222)

1. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P & Marino M 2005 Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Molecular Biology of the Cell 16 231-237. (doi:10. 1091/mbc. E04-07-0547)
2. Alarid ET, Bakopoulos N & Solodin N 1999 Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Molecular Endocrinology 13 1522-1534. (doi:10. 1210/ mend. 13. 9. 0337)
3. Alarid ET, Preisler-Maskek MT & Solodin NM 2006 Lives and times of nuclear receptors. Molecular Endocrinology 20 1972-1981. (doi:10. 1210/ me. 2005-0481)
4. Al-Hakim AK, Zagorska A, Chapman L, Deak M, Peggie M & Alessi DR 2008 Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. Biochemical Journal 411 249-260. (doi:10. 1042/BJ20080067)
5. Al-Hakim A, Escribano-Diaz C, Landry M-C, O'Donnell L, Panier S, Szilard RK & Durocher D 2010 The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair 9 1229-1240. (doi:10. 1016/j. dnarep. 2010. 09. 011)
6. Ali S, Metzger D, Bornert JM & Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO Journal 12 1153-1160.
7. Andersen RJ, Mawji NR, WangJ, Wang G, Haile S, Myung J-K, Watt K, TamT, Yang YC, Bañuelos CA et al. 2010 Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 17 535-546. (doi:10. 1016/ j. ccr. 2010. 04. 027)
8. Aranda A & Pascual A 2001 Nuclear hormone receptors and gene expression. Physiological Reviews 81 1269-1304.
9. Arnold SF, Vorojeikina DP & Notides AC 1995 Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. Journal of Biological Chemistry 270 30205-30212. (doi:10. 1074/jbc. 270. 4. 1850)
10. Bagatell R, Khan O, Paine-Murrieta G, Taylor CW, Akinaga S & Whitesell L 2001 Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clinical Cancer Research 7 2076-2084.
11. Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY & Patterson C 1999 Identification of CHIP, a novel tetratricopeptide repeatcontaining protein that interacts with heat shock proteins and negatively regulates chaperone functions. Molecular and Cellular Biology 19 4535-4545.
12. Bastien J, Adam-Stitah S, Riedl T, Egly JM, Chambon P & Rochette-Egly C 2000 TFIIH interacts with the retinoic acid receptor γ and phosphorylates its AF-1-activating domain through cdk7. Journal of Biological Chemistry 275 21896-21904. (doi:10. 1074/jbc. M001985200)
13. Beitel LK, Elhaji YA, Lumbroso R, Wing SS, Panet-Raymond V, Gottlieb B, Pinsky L & Trifiro MA 2002 Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitinprotein ligase activity. Journal of Molecular Endocrinology 29 41-60. (doi:10. 1677/jme. 0. 0290041)
14. Bernassola F, Karin M, Ciechanover A &Melino G 2008 The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14 10-21. (doi:10. 1016/j. ccr. 2008. 06. 001)
15. Berndsen CE & Wolberger C 2014 New insights into ubiquitin E3 ligase mechanism. Nature Structural & Molecular Biology 21 301-307. (doi:10. 1038/nsmb. 2780)
16. Bhatt S, Xiao Z, Meng Z & Katzenellenbogen BS 2012 Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCFSkp2 proteasomal complex. Molecular and Cellular Biology 32 1928-1943. (doi:10. 1128/MCB. 06561-11)
17. Bloom J & Pagano M 2003 Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Seminars in Cancer Biology 13 41-47. (doi:10. 1016/S1044-579X(02)00098-6)
18. Bremm A & Komander D 2011 Emerging roles for Lys11-linked polyubiquitin in cellular regulation. Trends in Biochemical Sciences 36355-363. (doi:10. 1016/j. tibs. 2011. 04. 004)
19. Bresnick EH, Dalman FC, Sanchez ER & Pratt WB 1989 Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. Journal of Biological Chemistry 264 4992-4997.
20. Brown JS & Jackson SP 2015 Ubiquitylation, neddylation and the DNA damage response. Open Biology 5 150018. (doi:10. 1098/rsob. 150018)
21. Bunone G, Briand PA, Miksicek RJ & Picard D 1996 Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO Journal 15 2174-2183.
22. Byun B & Jung Y 2008 Repression of transcriptional activity of estrogen receptor α by a Cullin3/SPOP ubiquitin E3 ligase complex. Molecules and Cells 25 289-293.
23. Caboni L & Lloyd DG 2013 Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors. Medicinal Research Reviews 33 1081-1118. (doi:10. 1002/med. 21275)
24. Calligé M, Kieffer I & Richard-Foy H 2005 CSN5/Jab1 is involved in liganddependent degradation of estrogen receptor {α} by the proteasome. Molecular and Cellular Biology 25 4349-4358. (doi:10. 1128/MCB. 25. 11. 4349-4358. 2005)
25. Calvo V & Beato M 2011 BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. Cancer Research 71 3422-3431. (doi:10. 1158/0008-5472. CAN-10-3670)
26. Cardozo CP, Michaud C, Ost MC, Fliss AE, Yang E, Patterson C, Hall SJ & Caplan AJ 2003 C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. Archives of Biochemistry and Biophysics 410 134-140. (doi:10. 1016/S0003-9861(02)00680-X)
27. Chamberlain PP, Lopez-Girona A, Miller K, Carmel G, Pagarigan B, Chie-Leon B, Rychak E, Corral LG, Ren YJ, WangMet al. 2014 Structure of the human cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs. Nature Structural & Molecular Biology 21 803-809. (doi:10. 1038/nsmb. 2874)
28. Chastagner P, Isrël A & Brou C 2006 Itch/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Reports 7 1147-1153. (doi:10. 1038/sj. embor. 7400822)
29. Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK & Varshavsky A 1989 A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243 1576-1583. (doi:10. 1126/ science. 2538923)
30. Chen J & Chen ZJ 2013 Regulation of NF-kB by ubiquitination. Current Opinion in Immunology 25 4-12. (doi:10. 1016/j. coi. 2012. 12. 005)
31. Chen D, Pace PE, Coombes RC & Ali S 1999 Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Molecular and Cellular Biology 19 1002-1015.
32. Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM & Ali S 2000 Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Molecular Cell 6 127-137. (doi:10. 1016/S1097-2765(05)00004-3)
33. Chymkowitch P, May NL, Charneau P, Compe E & Egly J-M 2011 The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process. EMBO Journal 30 468-479. (doi:10. 1038/ emboj. 2010. 337)
34. Cirit M, Grant KG & Haugh JM 2012 Systemic perturbation of the ERK signaling pathway by the proteasome inhibitor, MG132. PLoS ONE 7 e50975. (doi:10. 1371/journal. pone. 0050975)
35. Clark DE, Poteet-Smith CE, Smith JA & Lannigan DA 2001 Rsk2 allosterically activates estrogen receptor α by docking to the hormonebinding domain. EMBO Journal 20 3484-3494. (doi:10. 1093/emboj/20. 13. 3484)
36. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Höhfeld J & Patterson C 2001 The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nature Cell Biology 3 93-96. (doi:10. 1038/35070170)
37. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA & Cheng S 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. PNAS 97 8985-8990. (doi:10. 1073/pnas. 160257997). ?
38. Davidovich S, Ben-Izhak O, Shapira M, Futerman B & Hershko DD 2008 Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer. Breast Cancer Research 10 R63. (doi:10. 1186/bcr2122)
39. Deng C-X 2006 BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Research 34 1416-1426. (doi:10. 1093/nar/gkl010)
40. Deshaies RJ & Joazeiro CAP 2009 RING domain E3 ubiquitin ligases. Annual Review of Biochemistry 78 399-434. (doi:10. 1146/annurev. biochem. 78. 101807. 093809)
41. Di Croce L, Okret S, Kersten S, Gustafsson JA, Parker M, WahliW& BeatoM 1999 Steroid and nuclear receptors. EMBO Journal 18 6201-6210. (doi:10. 1093/emboj/18. 22. 6201)
42. Dikic I, Wakatsuki S & Walters KJ 2009 Ubiquitin-binding domains-from structures to functions. Nature Reviews. Molecular Cell Biology 10659-671. (doi:10. 1038/nrm2767)
43. Dizin E & Irminger-Finger I 2010 Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor α stability and activity antagonized by cancer-associated isoform of BARD1. International Journal of Biochemistry & Cell Biology 42 693-700. (doi:10. 1016/j. biocel. 2009. 12. 025)
44. Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H & Cavaillès V 2007 Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Research 67 5513-5521. (doi:10. 1158/0008-5472. CAN-07-0967)
45. Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL & Fon EA 2011 The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Human Molecular Genetics 20 141-154. (doi:10. 1093/hmg/ddq452)
46. Dynek JN, Goncharov T, Dueber EC, Fedorova AV, Izrael-Tomasevic A, Phu L, Helgason E, Fairbrother WJ, Deshayes K, Kirkpatrick DS et al. 2010 c-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO Journal 29 4198-4209. (doi:10. 1038/emboj. 2010. 300)
47. Eakin CM, MacCoss MJ, Finney GL & Klevit RE 2007 Estrogen receptor α is a putative substrate for the BRCA1 ubiquitin ligase. PNAS 104 5794-5799. (doi:10. 1073/pnas. 0610887104)
48. Elbi C, Walker DA, Romero G, Sullivan WP, Toft DO, Hager GL & DeFranco DB 2004 Molecular chaperones function as steroid receptor nuclear mobility factors. PNAS 101 2876-2881. (doi:10. 1073/pnas. 0400116101)
49. El Khissiin A & Leclercq G 1999 Implication of proteasome in estrogen receptor degradation. FEBS Letters 448 160-166. (doi:10. 1016/S0014-5793(99)00343-9)
50. Emanuele S, Calvaruso G, LauricellaM, GiulianoM, Bellavia G, D'Anneo A, Vento R & Tesoriere G 2002 Apoptosis induced in hepatoblastoma HepG2 cells by the proteasome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-XS and activation of caspase-3. International Journal of Oncology 21 857-865. (doi:10. 3892/ ijo. 21. 4. 857)
51. Emmerich CH, Ordureau A, Strickson S, Arthur JS, Pedrioli PG, Komander D & Cohen P 2013 Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. PNAS 110 15247-15252. (doi:10. 1073/ pnas. 1314715110)
52. Evans RM & Mangelsdorf DJ 2014 Nuclear receptors, RXR, and the big bang. Cell 157 255-266. (doi:10. 1016/j. cell. 2014. 03. 012)
53. Fan S, Wang J-A, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID et al. 1999 BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284 1354-1356. (doi:10. 1126/science. 284. 5418. 1354)
54. Fan M, Park A & Nephew KP 2005 CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-α. Molecular Endocrinology 19 2901-2914. (doi:10. 1210/me. 2005-0111)
55. Faresse N, Ruffieux-Daidie D, Salamin M, Gomez-Sanchez CE & Staub O 2010 Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP. American Journal of Physiology. Renal Physiology 299 F1462-F1472. (doi:10. 1152/ajprenal. 00285. 2010)
56. Fischer ES, Böhm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM et al. 2014 Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512 49-53. (doi:10. 1038/nature13527). ?
57. Freudenthal BD, Gakhar L, Ramaswamy S & Washington MT 2010 Structure of monoubiquitinated PCNA and implications for translesion synthesis and DNA polymerase exchange. Nature Structural & Molecular Biology 17 479-484. (doi:10. 1038/nsmb. 1776)
58. Gao X, Mohsin SK, Gatalica Z, Fu G, Sharma P & Nawaz Z 2005 Decreased expression of E6-associated protein in breast and prostate carcinomas. Endocrinology 146 1707-1712. (doi:10. 1210/en. 2004-1198)
59. Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ & Springer W 2010 PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology 12 119-131. (doi:10. 1038/ncb2012)
60. Glauser L, Sonnay S, Stafa K & Moore DJ 2011 Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. Journal of Neurochemistry 118 636-645. (doi:10. 1111/j. 1471-4159. 2011. 07318. x). ?
61. Goto E, Yamanaka Y, Ishikawa A, Aoki-Kawasumi M, Mito-Yoshida M, Ohmura-Hoshino M, Matsuki Y, Kajikawa M, Hirano H & Ishido S 2010 Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization. Journal of Biological Chemistry 285 35311-35319. (doi:10. 1074/jbc. M110. 112763)
62. Gronemeyer H, Gustafsson J-Å & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Reviews. Drug Discovery 3950-964. (doi:10. 1038/nrd1551)
63. Gunther JR, Parent AA & Katzenellenbogen JA 2009 Alternative inhibition of androgen receptor signaling: peptidomimetic pyrimidines as direct androgen receptor/coactivator disruptors. ACS Chemical Biology 4435-440. (doi:10. 1021/cb900043e)
64. Gustafsson N, Zhao C, Gustafsson J-Å & Dahlman-Wright K 2010 RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor α and cyclin B1. Cancer Research 70 1265-1274. (doi:10. 1158/0008-5472. CAN-09-2674)
65. Haglund K & Dikic I 2005 Ubiquitylation and cell signaling. EMBO Journal 24 3353-3359. (doi:10. 1038/sj. emboj. 7600808)
66. Hammes SR & Levin ER 2011 Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology 152 4489-4495. (doi:10. 1210/ en. 2011-1470)
67. He Y, Xu Y, Zhang C, Gao X, Dykema KJ, Martin KR, Ke J, Hudson EA, Khoo SK, Resau JH et al. 2011 Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. Science Signaling 4 ra44. (doi:10. 1126/scisignal. 4159ec44)
68. Held JM, Britton DJ, Scott GK, Lee EL, Schilling B, Baldwin MA, Gibson BW & Benz CC 2012 Ligand binding promotes CDK-dependent phosphorylation of ER-α on hinge serine 294 but inhibits ligandindependent phosphorylation of serine 305. Molecular Cancer Research 10 1120-1132. (doi:10. 1158/1541-7786. MCR-12-0099)
69. Helenius K, Yang Y, Alasaari J & Mäkelä TP 2009 Mat1 inhibits peroxisome proliferator-activated receptor γ-mediated adipocyte differentiation. Molecular and Cellular Biology 29 315-323. (doi:10. 1128/ MCB. 00347-08)
70. Henrich LM, Smith JA, Kitt D, Errington TM, Nguyen B, Traish AM & Lannigan DA 2003 Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction. Molecular and Cellular Biology 23 5979-5988. (doi:10. 1128/MCB. 23. 17. 5979-5988. 2003)
71. Hershko A & Ciechanover A 1998 The ubiquitin system. Annual Review of Biochemistry 67 425-479. (doi:10. 1146/annurev. biochem. 67. 1. 425)
72. Hilmi K, Hussein N, Mendoza-Sanchez R, El-Ezzy M, Ismail H, Durette C, Bail M, Rozendaal MJ, Bouvier M, Thibault P et al. 2012 Role of SUMOylation in full antiestrogenicity. Molecular and Cellular Biology 32 3823-3837. (doi:10. 1128/MCB. 00290-12)
73. Hoege C, Pfander B, Moldovan G-L, Pyrowolakis G & Jentsch S 2002 RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419 135-141. (doi:10. 1038/nature00991)
74. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG & Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 635-641. (doi:10. 1038/318635a0). ?
75. Huang K-T, Pavlides SC, Lecanda J, Blank SV, Mittal KR & Gold LI 2012 Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. PLoS ONE 7 e46072. (doi:10. 1371/journal. pone. 0046072)
76. Husnjak K & Dikic I 2012 Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annual Review of Biochemistry 81291-322. (doi:10. 1146/annurev-biochem-051810-094654)
77. Hwang C-S, Shemorry A, Auerbach D & Varshavsky A 2010 The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases. Nature Cell Biology 12 1177-1185. (doi:10. 1038/ncb2121)
78. Ikeda F, Deribe YL, Skånland SS, Stieglitz B, Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J et al. 2011 SHARPIN forms a linear ubiquitin ligase complex regulating NF-kB activity and apoptosis. Nature 471 637-641. (doi:10. 1038/nature09814)
79. Imhof MO & McDonnell DP 1996 Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Molecular and Cellular Biology 16 2594-2605.
80. Inoue S, Orimo A, Hosoi T, Kondo S, Toyoshima H, Kondo T, Ikegami A, Ouchi Y, Orimo H & Muramatsu M1993 Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. PNAS 90 11117-11121. (doi:10. 1073/pnas. 90. 23. 11117)
81. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y & Handa H 2010 Identification of a primary target of thalidomide teratogenicity. Science 327 1345-1350. (doi:10. 1126/science. 1177319)
82. Jackson SP & Durocher D 2013 Regulation of DNA damage responses by ubiquitin and SUMO. Molecular Cell 49 795-807. (doi:10. 1016/j. molcel. 2013. 01. 017)
83. Jensen EV, Desombre ER, Kawashima T, Suzuki T, Kyser K & Jungblut PW 1967 Estrogen-binding substances of target tissues. Science 158 529-530. (doi:10. 1126/science. 158. 3800. 529-c)
84. Jin L, Williamson A, Banerjee S, Philipp I & Rape M 2008 Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. Cell 133 653-665. (doi:10. 1016/j. cell. 2008. 04. 012)
85. Jing X, Infante J, Nachtman RG & Jurecic R 2008 E3 ligase FLRF (Rnf41) regulates differentiation of hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors. Experimental Hematology 36 1110-1120. (doi:10. 1016/j. exphem. 2008. 04. 001)
86. Johnsen SA, Güngör C, Prenzel T, Riethdorf S, Riethdorf L, Taniguchi-Ishigaki N, Rau T, Tursun B, Furlow JD, Sauter G et al. 2009 Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Research 69 128-136. (doi:10. 1158/0008-5472. CAN-08-1630)
87. Jung SY, Malovannaya A, Wei J, O'Malley BW & Qin J 2005 Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. Molecular Endocrinology 19 2451-2465. (doi:10. 1210/me. 2004-0476)
88. Jung Y-S, Lee S-J, Yoon M-H, Ha NC & Park B-J 2012 Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions. Cell Cycle 11 4462-4473. (doi:10. 4161/cc. 22794)
89. Kamata Y, Watanabe J, Nishimura Y, Arai T, Kawaguchi M, Hattori M, Obokata A & Kuramoto H 2005 High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma. Journal of Cancer Research and Clinical Oncology 131 591-596. (doi:10. 1007/s00432-005-0671-2)
90. Kar G, Keskin O, Nussinov R & Gursoy A 2012 Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. Journal of Proteome Research 11 1196-1207. (doi:10. 1021/pr2009143)
91. Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN & Foulkes WD 1997 Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80 435-441. (doi:10. 1002/(SICI)1097-0142 (19970801)80:3!435::AID-CNCR11O3. 0. CO;2-Y)
92. Kawai H, Li H, Chun P, Avraham S & Avraham HK 2002 Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 21 7730-7739. (doi:10. 1038/sj. onc. 1205971)
93. Kilroy G, Kirk-Ballard H, Carter LE & Floyd ZE 2012 The ubiquitin ligase Siah2 regulates PPARγ activity in adipocytes. Endocrinology 153 1206-1218. (doi:10. 1210/en. 2011-1725)
94. Kim MY, Woo EM, Chong YTE, Homenko DR & KrausWL 2006 Acetylation of estrogen receptor α by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Molecular Endocrinology 20 1479-1493. (doi:10. 1210/me. 2005-0531)
95. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ et al. 2011 Systematic and quantitative assessment of the ubiquitin-modified proteome. Molecular Cell 44 325-340. (doi:10. 1016/j. molcel. 2011. 08. 025)
96. Kim J-H, Park KW, Lee E-W, Jang W-S, Seo J, Shin S, Hwang K-A & Song J 2014 Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation. Cell Death and Differentiation 21 594-603. (doi:10. 1038/cdd. 2013. 181)
97. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M, Sano S, Tokunaga F, Tanaka K & Iwai K 2006 A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO Journal 25 4877-4887. (doi:10. 1038/sj. emboj. 7601360)
98. Kirkpatrick DS, Denison C & Gygi SP 2005 Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nature Cell Biology 7 750-757. (doi:10. 1038/ncb0805-750)
99. Komander D 2009 The emerging complexity of protein ubiquitination. Biochemical Society Transactions 37 937. (doi:10. 1042/BST0370937)
100. Komander D, Clague MJ & Urbé S 2009 Breaking the chains: structure and function of the deubiquitinases. Nature Reviews. Molecular Cell Biology 10 550-563. (doi:10. 1038/nrm2731). ?
101. Kopf E, Plassat J-L, Vivat V, de The H, Chambon P & Rochette-Egly C 2000 Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors α and γ through the ubiquitin-proteasome pathway. Journal of Biological Chemistry 275 33280-33288. (doi:10. 1074/jbc. M002840200)
102. Kulathu Y & Komander D 2012 Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nature Reviews. Molecular Cell Biology 13 508-523. (doi:10. 1038/nrm3394)
103. La Rosa P, Pesiri V, Marino M & Acconcia F 2011a 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α monoubiquitination. Cellular Signalling 23 1128-1135. (doi:10. 1016/j. cellsig. 2011. 02. 006)
104. La Rosa P, Marino M & Acconcia F 2011b 17β-estradiol regulates estrogen receptor α monoubiquitination. IUBMB Life 63 49-53. (doi:10. 1002/ iub. 414)
105. Lecanda J, Parekh TV, Gama P, Lin K, Liarski V, Uretsky S, Mittal K & Gold LI 2007 Transforming growth factor-β, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Research 67 1007-1018. (doi:10. 1158/0008-5472. CAN-06-0235)
106. Lee I & Schindelin H 2008 Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes. Cell 134 268-278. (doi:10. 1016/j. cell. 2008. 05. 046). ?
107. Lee MO, Kim EO, Kwon HJ, Kim YM, Kang HJ, Kang H & Lee JE 2002 Radicicol represses the transcriptional function of the estrogen receptor by suppressing the stabilization of the receptor by heat shock protein 90. Molecular and Cellular Endocrinology 188 47-54. (doi:10. 1016/S0303-7207(01)00753-5). ?
108. Le Goff P, Montano MM, Schodin DJ & Katzenellenbogen BS 1994 Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. Journal of Biological Chemistry 269 4458-4466.
109. Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K, Goddard S, Gobert-Gosse S & Corbo L 2008 Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Molecular Cell 31 212-221. (doi:10. 1016/j. molcel. 2008. 05. 025). ?
110. Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir J-M & Corbo L 2011 Cracking the estrogen receptor's posttranslational code in breast tumors. Endocrine Reviews 32 597-622. (doi:10. 1210/er. 2010-0016)
111. Li L, Li Z, Howley PM & Sacks DB 2006 E6AP and calmodulin reciprocally regulate estrogen receptor stability. Journal of Biological Chemistry 281 1978-1985. (doi:10. 1074/jbc. M508545200)
112. Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A & Srivastava S 2008 A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. Journal of Biological Chemistry 283 28988-28995. (doi:10. 1074/jbc. M710528200)
113. Li B, Lu W, Yang Q, Yu X, Matusik RJ & Chen Z 2014 Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer. Prostate 74 421-432. (doi:10. 1002/pros. 22763)
114. Licchesi JD, Mieszczanek J, Mevissen TE, Rutherford TJ, Akutsu M, Virdee S, El Oualid F, Chin JW, Ovaa H, Bienz M et al. 2012 An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains. Nature Structural & Molecular Biology 19 62-71. (doi:10. 1038/nsmb. 2169)
115. Likhite VS, Stossi F, Kim K, Katzenellenbogen BS & Katzenellenbogen JA 2006 Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Molecular Endocrinology 20 3120-3132. (doi:10. 1210/me. 2006-0068)
116. Lin H-K, Wang L, Hu Y-C, Altuwaijri S & Chang C 2002 Phosphorylationdependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO Journal 21 4037-4048. (doi:10. 1093/ emboj/cdf406). ?
117. Loman N, Johannsson O, Bendahl PO, Borg A, Fernö M & Olsson H 1998 Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83 310-319. (doi:10. 1002/(SICI)1097-0142(19980715)83:2!310::AIDCNCR15O3. 0. CO;2-W)
118. Lonard DM, Nawaz Z, Smith CL & O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Molecular Cell 5 939-948. (doi:10. 1016/S1097-2765(00)80259-2)
119. Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong K-K, Bradner JE & Kaelin WG 2014 The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343 305-309. (doi:10. 1126/science. 1244917)
120. Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA & Rosen EM 2010 BRCA1 regulates acetylation and ubiquitination of estrogen receptor-α. Molecular Endocrinology 24 76-90. (doi:10. 1210/me. 2009-0218)
121. Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, Ding C, Shi Y, Yucer N, Krenciute G et al. 2011 Analysis of the human endogenous coregulator complexome. Cell 145 787-799. (doi:10. 1016/ j. cell. 2011. 05. 006)
122. Malyukova A, Brown S, Papa R, O'Brien R, Giles J, Trahair TN, Dalla Pozza L, Sutton R, Liu T, Haber M et al. 2013 FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation. Leukemia 27 1053-1062. (doi:10. 1038/leu. 2012. 361)
123. Mao C, Patterson NM, Cherian MT, Aninye IO, Zhang C, Montoya JB, Cheng J, Putt KS, Hergenrother PJ, Wilson EM et al. 2008 A new small molecule inhibitor of estrogen receptor α binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. Journal of Biological Chemistry 283 12819-12830. (doi:10. 1074/jbc. M709936200)
124. Markson G, Kiel C, Hyde R, Brown S, Charalabous P, Bremm A, Semple J, Woodsmith J, Duley S, Salehi-Ashtiani K et al. 2009 Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Research 19 1905-1911. (doi:10. 1101/gr. 093963. 109). ?
125. Martiniani R, Di Loreto V, Di Sano C, Lombardo A & Liberati AM 2012 Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma. Advances in Hematology 2012 842945. (doi:10. 1155/2012/842945)
126. Matsumoto ML, Dong KC, Yu C, Phu L, Gao X, Hannoush RN, Hymowitz SG, Kirkpatrick DS, Dixit VM & Kelley RF 2012 Engineering and structural characterization of a linear polyubiquitin-specific antibody. Journal of Molecular Biology 418 134-144. (doi:10. 1016/j. jmb. 2011. 12. 053)
127. McDonnell DP & Wardell SE 2010 The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Current Opinion in Pharmacology 10620-628. (doi:10. 1016/j. coph. 2010. 09. 007). ?
128. Métivier R, Penot G, Hübner MR, Reid G, Brand H, KosM& Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763. (doi:10. 1016/S0092-8674(03)00934-6)
129. Michalides R, Griekspoor A, Balkenende A, Verwoerd D, Janssen L, Jalink K, Floore A, Velds A, van't Veer L & Neefjes J 2004 Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell 5 597-605. (doi:10. 1016/j. ccr. 2004. 05. 016)
130. Miesfeld R, Okret S, Wikström AC, Wrange O, Gustafsson JA & Yamamoto KR 1984 Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature 312 779-781. (doi:10. 1038/312779a0)
131. Mitsiades CS, Davies FE, Laubach JP, Joshua D, San Miguel J, Anderson KC & Richardson PG 2011 Future directions of next-generation novel therapies, combination approaches, and the development of personalized medicine in myeloma. Journal of Clinical Oncology 29 1916-1923. (doi:10. 1200/JCO. 2010. 34. 0760)
132. Moilanen AM, Poukka H, Karvonen U, Häkli M, Jänne OA & Palvimo JJ 1998 Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Molecular and Cellular Biology 18 5128-5139.
133. Morris JR & Solomon E 2004 BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Human Molecular Genetics 13807-817. (doi:10. 1093/hmg/ddh095)
134. Mukhopadhyay D & Riezman H 2007 Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315 201-205. (doi:10. 1126/science. 1127085)
135. Mund T, LewisMJ, Maslen S & Pelham HR 2014 Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. PNAS 111 16736-16741. (doi:10. 1073/pnas. 1412152111)
136. Nagaich AK, Walker DA, Wolford R & Hager GL 2004 Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Molecular Cell 14 163-174. (doi:10. 1016/S1097-2765(04)00178-9)
137. Nakajima A, Maruyama S, Bohgaki M, Miyajima N, Tsukiyama T, Sakuragi N & Hatakeyama S 2007 Ligand-dependent transcription of estrogen receptor α is mediated by the ubiquitin ligase EFP. Biochemical and Biophysical Research Communications 357 245-251. (doi:10. 1016/j. bbrc. 2007. 03. 134). ?
138. Nawaz Z, Lonard DM, Dennis AP, Smith CL & O'Malley BW 1999a Proteasome-dependent degradation of the human estrogen receptor. PNAS 96 1858-1862. (doi:10. 1073/pnas. 96. 5. 1858)
139. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai M-J & O'Malley BW 1999b The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Molecular and Cellular Biology 19 1182-1189.
140. Newton K, Matsumoto ML, Wertz IE, Kirkpatrick DS, Lill JR, Tan J, Dugger D, Gordon N, Sidhu SS, Fellouse FA et al. 2008 Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134 668-678. (doi:10. 1016/j. cell. 2008. 07. 039)
141. Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukuda M & Ohta T 2004 Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase. Journal of Biological Chemistry 279 3916-3924. (doi:10. 1074/jbc. M308540200)
142. Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM & McDonnell DP 1999 Peptide antagonists of the human estrogen receptor. Science 285 744-746. (doi:10. 1126/ science. 285. 5428. 744)
143. Pan X, Zhou T, Tai Y-H, Wang C, Zhao J, Cao Y, Chen Y, Zhang P-J, Yu M, Zhen C et al. 2011 Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer. Nature Medicine 17 708-714. (doi:10. 1038/nm. 2369)
144. Parent AA, Gunther JR & Katzenellenbogen JA 2008 Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding. Journal of Medicinal Chemistry 51 6512-6530. (doi:10. 1021/jm800698b)
145. Pavlides SC, Huang K-T, Reid DA, Wu L, Blank SV, Mittal K, Guo L, Rothenberg E, Rueda B, Cardozo T et al. 2013 Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer. Endocrinology 154 4030-4045. (doi:10. 1210/en. 2013-1757)
146. Peng J, Schwartz D, Elias JE, Thoreen CC, Cheng D, Marsischky G, Roelofs J, Finley D & Gygi SP 2003 A proteomics approach to understanding protein ubiquitination. Nature Biotechnology 21 921-926. (doi:10. 1038/ nbt849)
147. Peng D-J, Zeng M, Muromoto R, Matsuda T, Shimoda K, Subramaniam M, Spelsberg TC, WeiW-Z & Venuprasad K 2011 Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth. Journal of Immunology 186 5638-5647. (doi:10. 4049/jimmunol. 1003801)
148. Pesiri V, Rosa PL, Stano P & Acconcia F 2013 Identification of an estrogen receptor α non covalent ubiquitin-binding surface: role in 17βestradiol-induced transcriptional activity. Journal of Cell Science 126 2577-2582. (doi:10. 1242/jcs. 123307)
149. Phu L, Izrael-Tomasevic A, Matsumoto ML, Bustos D, Dynek JN, Fedorova AV, Bakalarski CE, Arnott D, Deshayes K, Dixit VM et al. 2011 Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Molecular & Cellular Proteomics 10 M110. 003756. (doi:10. 1074/mcp. M110. 003756)
150. Picard N, Charbonneau C, Sanchez M, Licznar A, Busson M, Lazennec G & Tremblay A 2008 Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor β. Molecular Endocrinology 22 317-330. (doi:10. 1210/me. 2007-0281)
151. Pickart CM 2001 Mechanisms underlying ubiquitination. Annual Review of Biochemistry 70 503-533. (doi:10. 1146/annurev. biochem. 70. 1. 503)
152. Poukka H, Aarnisalo P, Santti H, Jänne OA & Palvimo JJ 2000 Coregulator small nuclear RING finger protein (SNURF) enhances Sp1-and steroid receptor-mediated transcription by different mechanisms. Journal of Biological Chemistry 275 571-579. (doi:10. 1074/jbc. 275. 1. 571)
153. Powers GL, Ellison-Zelski SJ, Casa AJ, Lee AV & Alarid ET 2010 Proteasome inhibition represses ERα gene expression in ERC cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene 29 1509-1518. (doi:10. 1038/onc. 2009. 434)
154. Pratt WB 1997 The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annual Review of Pharmacology and Toxicology 37 297-326. (doi:10. 1146/annurev. pharmtox. 37. 1. 297)
155. Pratt WB & Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrine Reviews 18 306-360. (doi:10. 1210/edrv. 18. 3. 0303)
156. Prenzel T, Begus-Nahrmann Y, Kramer F, Hennion M, Hsu C, Gorsler T, Hintermair C, Eick D, Kremmer E, Simons M et al. 2011 Estrogendependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Research 71 5739-5753. (doi:10. 1158/0008-5472. CAN-11-1896)
157. Qi J, Tripathi M, Mishra R, Sahgal N, Fazil L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D et al. 2013 The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity. Cancer Cell 23 332-346. (doi:10. 1016/j. ccr. 2013. 02. 016)
158. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R, Kensche T, Uejima T, Bloor S, Komander D et al. 2009 Specific recognition of linear ubiquitin chains by NEMO is important for NF-kB activation. Cell 136 1098-1109. (doi:10. 1016/j. cell. 2009. 03. 007)
159. Rajbhandari P, Schalper KA, Solodin NM, Ellison-Zelski SJ, Ping Lu K, Rimm DL & Alarid ET 2014 Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene 33 1438-1447. (doi:10. 1038/onc. 2013. 78)
160. Ramamoorthy S & Nawaz Z 2008 E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nuclear Receptor Signaling 6 e006. (doi:10. 1621/nrs. 06006)
161. Reid G, Hübner MR, Métivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J & Gannon F 2003 Cyclic proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 11 695-707. (doi:10. 1016/ S1097-2765(03)00090-X)
162. Ren Y, Jiang H, Ma D, Nakaso K & Feng J 2011 Parkin degrades estrogenrelated receptors to limit the expression of monoamine oxidases. Human Molecular Genetics 20 1074-1083. (doi:10. 1093/hmg/ddq550). ?
163. Rochette-Egly C, Adam S, Rossignol M, Egly JM & Chambon P 1997 Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90 97-107. (doi:10. 1016/S0092-8674(00)80317-7)
164. Roy R, Chun J & Powell SN 2012 BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature Reviews. Cancer 12 68-78. (doi:10. 1038/nrc3181)
165. Sanchez M, Picard N, Sauvé K & Tremblay A 2013 Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals. Oncogene 32 117-126. (doi:10. 1038/onc. 2012. 19)
166. Saville B, Poukka H, WormkeM, Janne OA, Palvimo JJ, StonerM, Samudio I & Safe S 2002 Cooperative coactivation of estrogen receptor α in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. Journal of Biological Chemistry 277 2485-2497. (doi:10. 1074/jbc. M109021200)
167. Schulman BA & Harper JW 2009 Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nature Reviews. Molecular Cell Biology 10 319-331. (doi:10. 1038/nrm2673)
168. Searle MS, Garner TP, Strachan J, Long J, Adlington J, Cavey JR, Shaw B & Layfield R 2012 Structural insights into specificity and diversity in mechanisms of ubiquitin recognition by ubiquitin-binding domains. Biochemical Society Transactions 40 404-408. (doi:10. 1042/ BST20110729)
169. Sengupta S & Wasylyk B 2001 Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes and Development 15 2367-2380. (doi:10. 1101/gad. 202201). ?
170. Sentis S, Le Romancer M, Bianchin C, Rostan M-C & Corbo L 2005 Sumoylation of the estrogen receptor α hinge region regulates its transcriptional activity. Molecular Endocrinology 19 2671-2684. (doi:10. 1210/me. 2005-0042)
171. Sheeler CQ, Singleton DW & Khan SA 2003 Mutation of serines 104, 106, and 118 inhibits dimerization of the human estrogen receptor in yeast. Endocrine Research 29 237-255. (doi:10. 1081/ERC-120022321). ?
172. Shinohara K, Tomioka M, Nakano H, Toné S, Ito H & Kawashima S 1996 Apoptosis induction resulting from proteasome inhibition. Biochemical Journal 317 385-388.
173. Smith DF 1993 Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Molecular Endocrinology 7 1418-1429. (doi:10. 1210/mend. 7. 11. 7906860)
174. Smith DF & Toft DO 1993 Steroid receptors and their associated proteins. Molecular Endocrinology 7 4-11. (doi:10. 1210/mend. 7. 1. 8446107)
175. Sobhian B, Shao G, Lilli DR, Culhane AC, Moreau LA, Xia B, Livingston DM & Greenberg RA 2007 RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316 1198-1202. (doi:10. 1126/ science. 1139516)
176. Spence J, Gali RR, Dittmar G, Sherman F, Karin M & Finley D 2000 Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain. Cell 102 67-76. (doi:10. 1016/S0092-8674(00)00011-8)
177. 125I]iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain. Journal of Biological Chemistry 271 8831-8836. (doi:10. 1074/jbc. 271. 15. 8831)
178. Stavreva DA, Müller WG, Hager GL, Smith CL & McNally JG 2004 Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Molecular and Cellular Biology 24 2682-2697. (doi:10. 1128/MCB. 24. 7. 2682-2697. 2004)
179. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X & Vertino PM 2008 Regulation of estrogen receptor α by the SET7 lysine methyltransferase. Molecular Cell 30 336-347. (doi:10. 1016/j. molcel. 2008. 03. 022)
180. Sultana R, Theodoraki MA & Caplan AJ 2013 Specificity in the actions of the UBR1 ubiquitin ligase in the degradation of nuclear receptors. FEBS Open Bio 3 394-397. (doi:10. 1016/j. fob. 2013. 09. 003)
181. Sun J, Zhou W, Kaliappan K, Nawaz Z & Slingerland JM 2012 ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression. Molecular Endocrinology 26 1567-1577. (doi:10. 1210/me. 2012-1140)
182. Takano Y, Adachi S, Okuno M, Muto Y, Yoshioka T, Matsushima-Nishiwaki R, Tsurumi H, Ito K, Friedman SL, Moriwaki H et al. 2004 The RING finger protein, RNF8, interacts with retinoid X receptor α and enhances its transcription-stimulating activity. Journal of Biological Chemistry 279 18926-18934. (doi:10. 1074/jbc. M309148200)
183. Talukder AH, Mishra SK, Mandal M, Balasenthil S, Mehta S, Sahin AA, Barnes CJ & Kumar R 2003 MTA1 interacts with MAT1, a cyclindependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. Journal of Biological Chemistry 278 11676-11685. (doi:10. 1074/jbc. M209570200)
184. Tateishi Y, Sonoo R, Sekiya Y, Sunahara N, KawanoM, Wayama M, Hirota R, Kawabe Y, Murayama A, Kato S et al. 2006 Turning off estrogen receptor β-mediated transcription requires estrogen-dependent receptor proteolysis. Molecular and Cellular Biology 26 7966-7976. (doi:10. 1128/ MCB. 00713-06)
185. Teicher BA, Ara G, Herbst R, Palombella VJ & Adams J 1999 The proteasome inhibitor PS-341 in cancer therapy. Clinical Cancer Research 5 2638-2645.
186. Terpos E, Kanellias N, Christoulas D, Kastritis E & Dimopoulos MA 2013 Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma. OncoTargets and Therapy 6 531-538. (doi:10. 2147/OTT. S34498). ?
187. Teyssier C, Ou C-Y, Khetchoumian K, Losson R & Stallcup MR 2006 Transcriptional intermediary factor 1α mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators. Molecular Endocrinology 20 1276-1286. (doi:10. 1210/me. 2005-0393)
188. Thénot S, Henriquet C, Rochefort H & Cavaillès V 1997 Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. Journal of Biological Chemistry 272 12062-12068.
189. Thrower JS, Hoffman L, Rechsteiner M & Pickart CM 2000 Recognition of the polyubiquitin proteolytic signal. EMBO Journal 19 94-102. (doi:10. 1093/emboj/19. 1. 94)
190. Toft D & Gorski J 1966 A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. PNAS 55 1574-1581. (doi:10. 1073/pnas. 55. 6. 1574)
191. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K, Nakagawa T, Kato M, Murata S, Yamaoka S et al. 2009 Involvement of linear polyubiquitylation of NEMO in NF-kB activation. Nature Cell Biology 11123-132. (doi:10. 1038/ncb1821)
192. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S, Tanaka K, Nakano H & Iwai K 2011 SHARPIN is a component of the NF-kB-activating linear ubiquitin chain assembly complex. Nature 471 633-636. (doi:10. 1038/nature09815)
193. Totta P, Pesiri V, Marino M & Acconcia F 2014 Lysosomal function is involved in 17β-estradiol-induced estrogen receptor α degradation and cell proliferation. PLoS ONE 9 e94880. (doi:10. 1371/journal. pone. 0094880)
194. Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, Wongvipat J, Smith-Jones PM, Yoo D, Kwon A et al. 2009 Development of a secondgeneration antiandrogen for treatment of advanced prostate cancer. Science 324 787-790. (doi:10. 1126/science. 1168175)
195. Tzeng DZ &KlingeCM1996 Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability. Biochemical and Biophysical Research Communications 223 554-560. (doi:10. 1006/bbrc. 1996. 0933)
196. Valley CC, Métivier R, Solodin NM, Fowler AM, Mashek MT, Hill L & Alarid ET 2005 Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor α N terminus. Molecular and Cellular Biology 25 5417-5428. (doi:10. 1128/MCB. 25. 13. 5417-5428. 2005)
197. Vanaja DK, Mitchell SH, Toft DO & Young CY 2002 Effect of geldanamycin on androgen receptor function and stability. Cell Stress & Chaperones 7 55-64. (doi:10. 1379/1466-1268(2002)007!0055:EOGOARO2. 0. CO;2)
198. Van Wijk SJ & Timmers HT 2010 The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB Journal 24 981-993. (doi:10. 1096/fj. 09-136259)
199. VomBaur E, Zechel C, Heery D, HeineMJ, Garnier JM, Vivat V, Le Douarin B, Gronemeyer H, Chambon P & Losson R 1996 Differential liganddependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO Journal 15 110-124.
200. Wallace AD & Cidlowski JA 2001 Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. Journal of Biological Chemistry 276 42714-42721. (doi:10. 1074/ jbc. M106033200)
201. Wang X & DeFranco DB 2005 Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Molecular Endocrinology 19 1474-1482. (doi:10. 1210/me. 2004-0383)
202. Wang LH, Yang XY, Zhang X, An P, KimH-J, Huang J, Clarke R, Osborne CK, Inman JK, Appella E et al. 2006 Disruption of estrogen receptor DNAbinding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. Cancer Cell 10 487-499. (doi:10. 1016/j. ccr. 2006. 09. 015). ?
203. Weis KE, Ekena K, Thomas JA, Lazennec G & Katzenellenbogen BS 1996 Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Molecular Endocrinology 10 1388-1398. (doi:10. 1210/mend. 10. 11. 8923465)
204. Whitesell L & Cook P 1996 Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Molecular Endocrinology 10 705-712. (doi:10. 1210/mend. 10. 6. 8776730)
205. Wickliffe KE, Williamson A, Meyer H-J, Kelly A & Rape M 2011 K11-linked ubiquitin chains as novel regulators of cell division. Trends in Cell Biology 21 656-663. (doi:10. 1016/j. tcb. 2011. 08. 008)
206. Wijayaratne AL & McDonnell DP 2001 The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. Journal of Biological Chemistry 276 35684-35692. (doi:10. 1074/jbc. M101097200)
207. Wu W, Nishikawa H, Hayami R, Sato K, Honda A, Aratani S, Nakajima T, Fukuda M & Ohta T 2007 BRCA1 ubiquitinates RPB8 in response to DNA damage. Cancer Research 67 951-958. (doi:10. 1158/0008-5472. CAN-06-3187)
208. Wu-Baer F, Lagrazon K, Yuan W & Baer R 2003 The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. Journal of Biological Chemistry 278 34743-34746. (doi:10. 1074/jbc. C300249200)
209. Xu P & Peng J 2006 Dissecting the ubiquitin pathway by mass spectrometry. Biochimica et Biophysica Acta 1764 1940-1947. (doi:10. 1016/j. bbapap. 2006. 09. 004)
210. Xu P, Duong DM, Seyfried NT, Cheng D, Xie Y, Robert J, Rush J, Hochstrasser M, Finley D & Peng J 2009a Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137 133-145. (doi:10. 1016/j. cell. 2009. 01. 041)
211. Xu K, Shimelis H, Linn DE, Jiang R, Yang X, Sun F, Guo Z, Chen H, Li W, Chen H et al. 2009b Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination. Cancer Cell 15270-282. (doi:10. 1016/j. ccr. 2009. 02. 021)
212. Xu M, Skaug B, ZengW&Chen ZJ 2009c A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Molecular Cell 36 302-314. (doi:10. 1016/j. molcel. 2009. 10. 002)
213. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ & Israël A 1998 Complementation cloning of NEMO, a component of the IkB kinase complex essential for NF-kB activation. Cell 93 1231-1240. (doi:10. 1016/S0092-8674(00)81466-X)
214. Yang CH, Gonzalez-Angulo AM, Reuben JM, Booser DJ, Pusztai L, Krishnamurthy S, Esseltine D, Stec J, Broglio KR, Islam R et al. 2006 Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. Annals of Oncology 17 813-817. (doi:10. 1093/annonc/mdj131)
215. Ye Y & Rape M 2009 Building ubiquitin chains: E2 enzymes at work. Nature Reviews. Molecular Cell Biology 10 755-764. (doi:10. 1038/ nrm2780)
216. Yokota K, Shibata H, Kobayashi S, Suda N, Murai A, Kurihara I, Saito I & Saruta T 2004 Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone. Endocrine Research 30 611-616. (doi:10. 1081/ERC-200043783)
217. Yudt MR, Vorojeikina D, Zhong L, Skafar DF, Sasson S, Gasiewicz TA & Notides AC 1999 Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation. Biochemistry 38 14146-14156. (doi:10. 1021/bi9911132)
218. Zhang P-J, Zhao J, Li H-Y, Man J-H, He K, Zhou T, Pan X, Li A-L, Gong W-L, Jin B-F et al. 2007 CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome. EMBO Journal 26 1831-1842. (doi:10. 1038/sj. emboj. 7601602)
219. Zhao J, Zhang Z, Vucetic Z, Soprano KJ & Soprano DR 2009 HACE1: a novel repressor of RAR transcriptional activity. Journal of Cellular Biochemistry 107 482-493. (doi:10. 1002/jcb. 22146)
220. Zheng L, Annab LA, Afshari CA, LeeWH & Boyer TG 2001 BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. PNAS 98 9587-9592. (doi:10. 1073/pnas. 171174298)
221. Zhu J, Gianni M, Kopf E, Honoré N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C & de The H 1999 Retinoic acid induces proteasomedependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins. PNAS 96 14807-14812. (doi:10. 1073/ pnas. 96. 26. 14807)
222. Zhu J, Zhao C, Kharman-Biz A, Zhuang T, Jonsson P, Liang N, Williams C, Lin C-Y, Qiao Y, Zendehdel K et al. 2014 The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation. Oncogene 33 4340-4351. (doi:10. 1038/onc. 2013. 573)